AL AmyloidosisÉstelle Desport, Arnaud Jaccard, Frank Bridoux et al.|Orphanet Journal of Rare Diseases|2012Cited by 264
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)Arnaud Jaccard, Chris Venner, Raymond L. Comenzo et al.|Haematologica|2014Cited by 132
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosisMurielle Roussel, Arnaud Jaccard, Giampaolo Merlini et al.|Blood|2020Cited by 128
Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndromeSébastien Bender, Arnaud Jaccard, Vincent Javaugue et al.|Blood|2020Cited by 45
Diagnostic score of cardiac involvement in AL amyloidosisMartin Nicol, Damien Logeart, Marguerite Vignon et al.|European Heart Journal - Cardiovascular Imaging|2019Cited by 44